CDC Will Not Investigate Mild Infections in Vaccinated Americans

The Coronavirus Outbreak liveLatest Updates Maps and Cases State Reopening Tracker Vaccine Rollout Vaccines and Children Advertisement Continue reading the main story Supported by Continue reading the main story C.D.C. Will Not Investigate Mild Infections in Vaccinated Americans At least 10,000 vaccinated people were infected with the coronavirus through the end of April. Now the… Read More »

Overdose deaths during pandemic may be linked to mental healthcare access

According to experts, difficulties in accessing mental healthcare could be linked to excess deaths due to drug overdoses during the pandemic. On Monday, the Bipartisan Policy Center and the polling firm Morning Consult released a survey of 2,200 adults that found many faced significant barriers in accessing mental healthcare. This follows a newly released study… Read More »

Blind Man’s Sight Partially Restored with ‘Optogenetics’ Gene Therapy

Advertisement Continue reading the main story Supported by Continue reading the main story Matter Scientists Partially Restored a Blind Man’s Sight With New Gene Therapy Using a technique called optogenetics, researchers added light-sensitive proteins to the man’s retina, giving him a blurry view of objects. In an experiment, a 58-year-old volunteer with a genetic form… Read More »

FDA Approves Rybrevant (amivantamab-vmjw) as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

FDA Approves Rybrevant (amivantamab-vmjw) as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations May 21, 2021 (HORSHAM, P.A.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of Rybrevant (amivantamab-vmjw) for the… Read More »